These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31261818)

  • 21. A Derivative of Differentiation-Inducing Factor-3 Inhibits PAK1 Activity and Breast Cancer Cell Proliferation.
    Oladimeji P; Kubohara Y; Kikuchi H; Oshima Y; Rusch C; Skerl R; Diakonova M
    Int J Cancer Clin Res; 2015; 2(3):1-6. PubMed ID: 26688830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel DIF-1 derivatives that selectively suppress innate immune responses.
    Nguyen VH; Kikuchi H; Kubohara Y; Takahashi K; Katou Y; Oshima Y
    Bioorg Med Chem; 2015 Aug; 23(15):4311-4315. PubMed ID: 26122773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagic or necrotic cell death triggered by distinct motifs of the differentiation factor DIF-1.
    Luciani MF; Kubohara Y; Kikuchi H; Oshima Y; Golstein P
    Cell Death Differ; 2009 Apr; 16(4):564-70. PubMed ID: 19079140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
    Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of IL-2 production in Jurkat cells by Dictyostelium-derived factors.
    Takahashi K; Murakami M; Hosaka K; Kikuchi H; Oshima Y; Kubohara Y
    Life Sci; 2009 Sep; 85(11-12):438-43. PubMed ID: 19632244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent.
    Kubohara Y
    Eur J Pharmacol; 1999 Sep; 381(1):57-62. PubMed ID: 10528134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation-inducing factor-1 and -2 function also as modulators for Dictyostelium chemotaxis.
    Kuwayama H; Kubohara Y
    PLoS One; 2009 Aug; 4(8):e6658. PubMed ID: 19684855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation-inducing factor from the slime mould Dictyostelium discoideum and its analogues. Synthesis, structure and biological activity.
    Masento MS; Morris HR; Taylor GW; Johnson SJ; Skapski AC; Kay RR
    Biochem J; 1988 Nov; 256(1):23-8. PubMed ID: 3223901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation, Synthesis, and Biological Activity of Chlorinated Alkylresorcinols from Dictyostelium Cellular Slime Molds.
    Kikuchi H; Ito I; Takahashi K; Ishigaki H; Iizumi K; Kubohara Y; Oshima Y
    J Nat Prod; 2017 Oct; 80(10):2716-2722. PubMed ID: 28921976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral administration of Dictyostelium differentiation-inducing factor 1 lowers blood glucose levels in streptozotocin-induced diabetic rats.
    Kawaharada R; Nakamura A; Takahashi K; Kikuchi H; Oshima Y; Kubohara Y
    Life Sci; 2016 Jun; 155():56-62. PubMed ID: 27131631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small Molecular Leads Differentially Active Against HER2 Positive and Triple Negative Breast Cancer Cell Lines.
    Badran A; Atia-Tul-Wahab ; Fayyaz S; Baydoun E; Choudhary MI
    Med Chem; 2019; 15(7):738-742. PubMed ID: 30398120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of an antibody that recognizes and neutralizes Dictyostelium differentiation-inducing factor-1.
    Kubohara Y; Kikuchi H; Nakamura K; Matsuo Y; Oshima Y
    Biochem Biophys Res Commun; 2010 May; 396(2):364-9. PubMed ID: 20416278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proximal pathway of metabolism of the chlorinated signal molecule differentiation-inducing factor-1 (DIF-1) in the cellular slime mould Dictyostelium.
    Morandini P; Offer J; Traynor D; Nayler O; Neuhaus D; Taylor GW; Kay RR
    Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):735-43. PubMed ID: 7702568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells.
    Abdullah ML; Hafez MM; Al-Hoshani A; Al-Shabanah O
    BMC Complement Altern Med; 2018 Dec; 18(1):321. PubMed ID: 30518369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-D-aspartate receptor-dependent and -independent cytotoxic effects of Dictyostelium discoideum differentiation-inducing factor-1 on rat cortical neurons.
    Kanno T; Kubohara Y; Goto F; Takata K; Hayashi K
    Dev Growth Differ; 2001 Dec; 43(6):709-16. PubMed ID: 11737151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sn- and Ge- triorganometallics exert different cytotoxicity and modulation of migration in triple-negative breast cancer cell line MDA-MB-231.
    Hunakova L; Brtko J
    Toxicol Lett; 2017 Sep; 279():16-21. PubMed ID: 28709983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Br-DIF-1 accelerates dimethyl sulphoxide-induced differentiation of P19CL6 embryonic carcinoma cells into cardiomyocytes.
    Seya K; Kanemaru K; Matsuki M; Hongo K; Kitahara H; Kikuchi H; Oshima Y; Kubohara Y; Okumura K; Motomura S; Furukawa KI
    Br J Pharmacol; 2012 Feb; 165(4):870-9. PubMed ID: 21671902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.